AU6526694A
(en)
*
|
1993-03-29 |
1994-10-24 |
Alza Corporation |
Biodegradable, water-permeable membrane for fluid-imbibing pump
|
US5827538A
(en)
*
|
1993-07-22 |
1998-10-27 |
Pfizer Inc. |
Osmotic devices having vapor-permeable coatings
|
US5798119A
(en)
*
|
1995-06-13 |
1998-08-25 |
S. C. Johnson & Son, Inc. |
Osmotic-delivery devices having vapor-permeable coatings
|
US6395292B2
(en)
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6132420A
(en)
*
|
1996-02-02 |
2000-10-17 |
Alza Corporation |
Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
|
ZA9710342B
(en)
*
|
1996-11-25 |
1998-06-10 |
Alza Corp |
Directional drug delivery stent and method of use.
|
US5954966A
(en)
*
|
1997-01-31 |
1999-09-21 |
University Of Ottawa |
Membrane composition and method of preparation
|
EP1325741B1
(en)
*
|
1997-03-24 |
2007-06-06 |
Alza Corporation |
Implantable delivery device with self adjustable exit port
|
ZA981610B
(en)
*
|
1997-03-24 |
1999-08-26 |
Alza Corp |
Self adjustable exit port.
|
DE19835346A1
(de)
*
|
1998-08-05 |
2000-02-10 |
Boehringer Ingelheim Pharma |
Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
|
DK1140012T3
(da)
*
|
1998-12-17 |
2004-07-12 |
Alza Corp |
Omdannelse af væskefyldte gelatinekapsler til systemer til kontrolleret frigivelsessystemer ved flere coatinger
|
US6491683B1
(en)
*
|
1999-09-07 |
2002-12-10 |
Alza Corporation |
Osmotic dosage form composed of an extruded polymer tube form
|
ATE306908T1
(de)
|
1999-12-21 |
2005-11-15 |
Alza Corp |
Ventil für osmotische vorrichtungen
|
CA2395231C
(en)
|
1999-12-23 |
2006-08-15 |
Pfizer Products Inc. |
Hydrogel-driven layered drug dosage form
|
EP1967185A1
(en)
*
|
1999-12-23 |
2008-09-10 |
Pfizer Products Inc. |
Hydrogel-driven drug dosage form
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
ES2291333T3
(es)
|
2000-06-27 |
2008-03-01 |
Qualilife Pharmaceuticals Inc. |
Composiciones y metodos para el tratamiento de la respuesta sexual de las mujeres.
|
PL362687A1
(en)
*
|
2001-01-12 |
2004-11-02 |
Sun Pharmaceutical Industries Limited |
Spaced drug delivery system
|
EP1372753B1
(de)
|
2001-02-16 |
2007-08-01 |
Abbott Laboratories Vascular Enterprises Limited |
Implantate mit fk506 zur restenosebehandlung und -prophylaxe
|
JP5328071B2
(ja)
*
|
2001-04-10 |
2013-10-30 |
サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド |
時限パルス放出組成物
|
US6632217B2
(en)
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
AU2002324447B2
(en)
*
|
2001-06-22 |
2006-06-29 |
Durect Corporation |
Zero-order prolonged release coaxial implants
|
US6949154B2
(en)
*
|
2001-07-28 |
2005-09-27 |
Boehringer Ingelheim Pharma Kg |
Method and apparatus for sealing medicinal capsules
|
WO2003024357A2
(en)
|
2001-09-14 |
2003-03-27 |
Martin Francis J |
Microfabricated nanopore device for sustained release of therapeutic agent
|
TWI222997B
(en)
*
|
2001-12-10 |
2004-11-01 |
Ind Tech Res Inst |
Method for tissue culture in vitro
|
BR0311897A
(pt)
*
|
2002-06-17 |
2005-04-05 |
Alza Corp |
Sistema de liberação osmótica com mecanismo de potência de impulso de ordem zero inicial compreendendo um agente osmótico disperso no veìculo fluido
|
CN100453130C
(zh)
*
|
2002-06-26 |
2009-01-21 |
精达制药公司 |
用于渗透性药物传递***的最低顺应性和高容积效率的活塞
|
AU2003250913A1
(en)
*
|
2002-07-08 |
2004-01-23 |
Abbott Laboratories Vascular Enterprises Limited |
Drug eluting stent and methods of manufacture
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
US20060210633A1
(en)
*
|
2003-04-03 |
2006-09-21 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
EP3470108A1
(en)
*
|
2004-07-02 |
2019-04-17 |
Mati Therapeutics Inc. |
Treatment medium delivery device for delivery of treatment media to the eye
|
US7117870B2
(en)
*
|
2004-07-26 |
2006-10-10 |
Clarity Corporation |
Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
|
DE102004042578A1
(de)
*
|
2004-09-02 |
2006-03-23 |
Roche Diagnostics Gmbh |
Mikropumpe zur Förderung von Flüssigkeiten mit niedrigen Förderraten im Druck/Saug-Betrieb
|
DE102005001332A1
(de)
*
|
2005-01-11 |
2006-07-20 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
|
US20080009423A1
(en)
|
2005-01-31 |
2008-01-10 |
Halliburton Energy Services, Inc. |
Self-degrading fibers and associated methods of use and manufacture
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US8801694B2
(en)
*
|
2005-08-11 |
2014-08-12 |
Massachusetts Institute Of Technology |
Intravesical drug delivery device
|
KR101106510B1
(ko)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
투피스, 내부채널 삼투압 전달 시스템 유동 조절기
|
MX2009001114A
(es)
|
2006-08-09 |
2009-02-10 |
Intarcia Therapeutics Inc |
Sistemas de suministro osmotico y ensambles de piston.
|
EP2083801A1
(en)
*
|
2006-11-30 |
2009-08-05 |
Accu-Break Technologies, Inc. |
Divisible osmotic dosage forms and methods of use
|
RU2440097C2
(ru)
|
2007-04-23 |
2012-01-20 |
Интарсия Терапьютикс, Инк. |
Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
|
NZ585449A
(en)
|
2007-12-11 |
2012-07-27 |
Massachusetts Inst Technology |
Implantable drug delivery device and methods for treatment of the bladder and other body vestcles or lumens
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
CA2733468C
(en)
|
2008-08-09 |
2017-12-05 |
Massachusetts Institute Of Technology |
Implantable drug delivery device and methods of treating male genitourinary and surrounding tissues
|
SG177360A1
(en)
|
2009-06-26 |
2012-02-28 |
Taris Biomedical Inc |
Implantable drug delivery devices and methods of making the same
|
EP2461818B1
(en)
|
2009-08-03 |
2018-10-17 |
Incube Labs, Llc |
Swallowable capsule and method for stimulating incretin production within the intestinal tract
|
US9017312B2
(en)
|
2009-09-10 |
2015-04-28 |
Taris Biomedical Llc |
Implantable device for controlled drug delivery
|
SI2462246T1
(en)
|
2009-09-28 |
2018-01-31 |
Intarcia Therapeutics, Inc. |
Fast-setting and / or cessation of substantially unchanged delivery of the product
|
PL2512581T3
(pl)
*
|
2009-12-17 |
2021-11-02 |
Taris Biomedical Llc |
Wszczepiane urządzenie z tolerancją wewnątrzpęcherzową
|
US8759284B2
(en)
|
2009-12-24 |
2014-06-24 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9402806B2
(en)
|
2010-12-23 |
2016-08-02 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9629799B2
(en)
|
2010-12-23 |
2017-04-25 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US8764733B2
(en)
|
2010-12-23 |
2014-07-01 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US8846040B2
(en)
|
2010-12-23 |
2014-09-30 |
Rani Therapeutics, Llc |
Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US8809269B2
(en)
|
2010-12-23 |
2014-08-19 |
Rani Therapeutics, Llc |
Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US8980822B2
(en)
|
2010-12-23 |
2015-03-17 |
Rani Therapeutics, Llc |
Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US8734429B2
(en)
|
2010-12-23 |
2014-05-27 |
Rani Therapeutics, Llc |
Device, system and methods for the oral delivery of therapeutic compounds
|
US9284367B2
(en)
|
2010-12-23 |
2016-03-15 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9415004B2
(en)
|
2010-12-23 |
2016-08-16 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US8969293B2
(en)
|
2010-12-23 |
2015-03-03 |
Rani Therapeutics, Llc |
Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9149617B2
(en)
|
2010-12-23 |
2015-10-06 |
Rani Therapeutics, Llc |
Device, system and methods for the oral delivery of therapeutic compounds
|
US10639272B2
(en)
|
2010-12-23 |
2020-05-05 |
Rani Therapeutics, Llc |
Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9402807B2
(en)
|
2010-12-23 |
2016-08-02 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US8809271B2
(en)
|
2010-12-23 |
2014-08-19 |
Rani Therapeutics, Llc |
Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9283179B2
(en)
|
2010-12-23 |
2016-03-15 |
Rani Therapeutics, Llc |
GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9861683B2
(en)
|
2010-12-23 |
2018-01-09 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9259386B2
(en)
|
2010-12-23 |
2016-02-16 |
Rani Therapeutics, Llc |
Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
RU2620032C2
(ru)
|
2011-01-10 |
2017-05-22 |
Аллерган, Инк. |
Схема приема лидокаина для применения в продолжительном лечении боли в мочевом пузыре и раздражения при мочеиспускании
|
ES2637388T3
(es)
|
2011-02-04 |
2017-10-13 |
Taris Biomedical, Inc. |
Dispositivo implantable para la liberación controlada de un fármaco de baja solubilidad
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
BR112015022433B1
(pt)
|
2013-03-15 |
2022-06-21 |
Taris Biomedical Llc |
Dispositivo de liberação de droga intravesical
|
PT3035991T
(pt)
|
2013-08-19 |
2020-10-06 |
Taris Biomedical Llc |
Métodos e dispositivos de unidades múltiplas para administração de fármacos
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
WO2016172704A1
(en)
|
2015-04-23 |
2016-10-27 |
Taris Biomedical Llc |
Drug delivery devices with drug-permeable component and methods
|
WO2016196112A1
(en)
*
|
2015-05-29 |
2016-12-08 |
Zebrasci, Inc. |
Biopolymer-based emulsion lubricants for syringe barrels
|
EP3302354B1
(en)
|
2015-06-03 |
2023-10-04 |
i2o Therapeutics, Inc. |
Implant placement systems
|
EP3733694A1
(en)
|
2016-05-16 |
2020-11-04 |
Intarcia Therapeutics, Inc |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
EP4353319A3
(en)
|
2016-09-28 |
2024-06-05 |
Atossa Therapeutics, Inc. |
Methods of adoptive cell therapy
|
MX2019008006A
(es)
|
2017-01-03 |
2019-08-29 |
Intarcia Therapeutics Inc |
Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|